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Abstract
Background: Tuberculosis is still a great challenge to public health in Brazil and worldwide. Early
detection followed by effective therapy is extremely important in controlling the disease. Recent
studies have investigated reasons for delays in treatment, but there is no agreed definition of what
constitutes an "acceptable" delay. This study investigates factors associated with total delay in
treatment of tuberculosis.
Methods: A cohort of adult cases of pulmonary tuberculosis diagnosed over a two-year period
was studied. Patients were interviewed on entry, reporting the duration of symptoms before the
start of treatment, and sputum and blood samples were collected. It was decided that sixty days
was an acceptable total delay. Associations were investigated using univariable and multivariable
analysis and the population attributable fraction was estimated.
Results: Of 1105 patients, 62% had a delay of longer than 60 days. Age, sex, alcoholism and
difficulty of access were not associated with delays, but associations were found in the case of
unemployment, having given up smoking, having lost weight and being treated in two of the six
health districts. The proportion attributable to: not being an ex-smoker was 31%; unemployment,
18%; weight loss, 12%, and going to the two worst health districts, 25%.
Conclusion: In this urban area, delays seem to be related to unemployment and general attitudes
towards health. Although they reflect the way health services are organized, delays are not
associated with access to care.
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Background
Tuberculosis is still a great challenge for public health in
Brazil and worldwide. In Recife, a large city in the North-
east Region of the country, the annual incidence of tuber-
culosis is high, about 100 per 100 000 inhabitants in
2003.
Early detection of infectious tuberculosis cases followed
by effective treatment is extremely important in control-
ling the disease, mainly because it can be assumed that the
time of infection is likely to pre-date the positive sputum
test by some time [1]. Because of this, recent studies have
investigated reasons for delays in treatment [2-8].
The starting point from which the delays are measured is
uncertain and there is no agreed definition as to what con-
stitutes an acceptable delay. The cut off point in studies of
risk factors for an acceptable delay has been defined in
two ways: either a panel of experts agrees on a reasonable
period of time or, alternatively, the median delay in
observed data is used. Panels of expert have agreed on an
acceptable total delay of 30 days [9,10] or 60 days [11,12].
Ward et al. [13] have criticized this approach, suggesting
that what is an acceptable delay should depend on the
local health services and the local epidemiological situa-
tion, with a shorter delay to be expected when incidence
is high.
Studies using the median observed total delay as the cut
off point found medians ranging from 2 to 4 months
[2,3,8,14-16]. Studies using the median patient delay
found medians ranging from 1 to 4 months
[2,3,7,13,9,17,10]. Studies restricted to smear-positive
cases have tended to find lower median patient delays
[8,16].
Risk factors identified in the literature as associated with
long total delays before treatment include: those relating
to perception and knowledge (inadequate knowledge
about TB) [5,7,9], lack of perception of the need to seek
health care [18]; those relating to the difficulty of access to
health care (living in rural areas)[14], and distance from
health care units [7,8]; those relating to the severity or spe-
cificity of symptoms (vagueness of symptoms, absence of
haemoptysis [5,14,9,16], negative smears [2]; those relat-
ing to old age [2,13,14,16], female sex [11,6,19,20], eth-
nic group (white patients) [6] and alcoholism [8]. The
only study of delay between the onset of symptoms and
treatment in patients with pulmonary tuberculosis carried
out in Brazil did not look at risk factors [21].
The aim of this study was to investigate biological, clini-
cal, social, life-style and health-care factors associated
with total treatment delay among cases of tuberculosis in
residents of Recife, to identify the main constraints on
early detection of patients and thus help with deciding
which measures to use to decrease tuberculosis transmis-
sion in Recife.
Methods
This was an observational study consisting of a cohort of
cases of pulmonary TB, aged 18 years or more, diagnosed
in Recife between May 2001 and May 2003. Case finding,
mostly passive, is one of the main activities of the national
tuberculosis control program (TCP). Decentralization has
been underway since 2000, with the progressive transfer
of activities from tuberculosis (TB) reference units to pri-
mary care units, as part of the Family Health Program
(FHP) [22]. One of the activities of FHP staff is to detect
people with respiratory symptoms (a cough persisting for
three or more weeks) and to have their sputum examined.
Patients were invited to participate in the study when the
decision to start treatment was taken, i.e. when the diag-
nosis of tuberculosis was given according to the criteria
established by the Ministry of Health. After signing the
informed consent form they were interviewed by trained
assistant nurses using a standard questionnaire, and had
sputum and blood samples collected for examination.
Patients were asked how long ago they first showed symp-
toms of pulmonary tuberculosis. In this way, the total
delay (from onset of symptoms to start of tuberculosis
treatment) was ascertained directly from the patients.
Patients were not aware if they had acceptable or unac-
ceptable delay; thus, recall bias, if it occurred, was likely to
be non-differential.
To define acceptable total delay we worked with two cut
off points: sixty and ninety days. An analysis of risk factors
for delays of ninety days or more (the median of our data)
found essentially the same factors in the univariable anal-
ysis as with sixty days, but only smoking and loss of
weight remained in the final multivariable model. We
concluded that a cut off point of sixty days enables more
potential public health interventions to be identified.
Exposures studied included biological factors (age and
sex), alcohol consumption, social factors (employment
status, marital status, literacy; numbers of dwellers in res-
idence, and income of the head of the household), history
of contact with other cases of tuberculosis (knowing
somebody with TB, early contact with TB patient, and liv-
ing in the same house as a TB patient), clinical factors
(previous tuberculosis treatment, cough, weight loss, acid-
fast bacilli smear result, HIV co-infection, and haemopty-
sis), the Health District in which unit of treatment is
located, and access to health services (number of health
units attended with this complaint before start of treat-
ment; whether unit of treatment is the local health center
and whether it is in the district of residence; whether the
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Family Health Program had been implemented in the area
of residence).
The univariable OR of unacceptable treatment delay was
estimated for biological factors, alcohol consumption,
social factors, history of contact with other cases of tuber-
culosis, clinical factors, the health district in which treat-
ment was carried out, and access to health services. The
significance of these associations was tested using the chi-
squared test and p-values were calculated. All variables
with a univariable association with a p-value ≤ 0.20 were
included in a multiple logistic regression analysis. Crude
and adjusted ORs and 95% CIs were calculated. The
attributable-risk percentages in the final model were cal-
culated as , where RR was the adjusted
OR for each variable.
Results
Of 1126 cases of pulmonary TB in the study population,
21 (1.9 %) were excluded because of lack of information
about the time of onset of symptoms, leaving 1105
patients for the study. The patients excluded were similar
to those included in terms of characteristics identified as
predictors of delay in the univariable analysis, with the
exception of weight loss. The mean total delay was 142
days, the median 90 days (120 in men and 90 in women).
Sixty-two percent of patients had a total delay of longer
than 60 days (which we consider an unacceptable delay in
this analysis). In 18%, the delay was longer than 181 days.
Tables 1 to 5 show the results of univariable analysis of
risk factors for unacceptable total delay. No association
with delay was found in the case of: sex, age, neither heavy
nor light alcohol consumption (table 1), literacy, income
of head of household, marital status of case, size of house-
hold (table 2); history of contact with a case of tuberculo-
sis (table 3); any clinical factor other than weight loss
(including smear-positive test result) (table 4); and any
factor concerning access to health services, except for dis-
trict of treatment (table 5).
Table 6 presents the results of the multivariable analysis.
All variables that were significant in the univariable anal-
ysis remained so in the multivariable analysis. The factors
significantly associated with delay were: being
unemployed (OR = 1.4; 95% CI: 1.09 – 1.81); not having
weight loss as one of the symptoms (OR = 1.54; 95% CI:
1.16 – 2.04); and treatment in two of the six districts (OR
= 2.34; 95% CI: 1.57 to 3.47 and OR = 1.92 95% CI: 1.35
to 2.73). The unacceptable delay attributable to each of
these factors was: unemployment, 28.6%, not having
weight loss, 35.1%, and being treated at health districts III
and V, 57.3% and 47.9% respectively.
Table 1: Biological factors, alcohol and tobacco consumption and total delay in pulmonary tuberculosis treatment. Recife, 2001–2003.
Total delay in treatment
Biological factors Unacceptable (> 60 days) Acceptable (≤ 60 days) Crude OR 95% CI P value
N % N %
Sex
Male 470 63.4 271 36.6 1.00 - -
Female 216 59.3 148 40.7 1.18 0.91 – 1.53 0.1884
Total 686 - 419 - - - -
Age (years) 0.1810
18–39 344 60.2 227 39.8 1.00 - -
40–59 280 65.4 148 34.6 1.24 0.96 – 1.61 0.0949
≥ 60 62 58.5 44 41.5 0.92 0.61 – 1.41 0.7349
Total 686 - 419 - - - -
Alcohol consumption 0.5575
None 338 60.7 219 39.3 1.00 - -
Light drinker 214 61.5 134 38.5 1.03 0.78 – 1.36 0.8075
Heavy drinker 83 65.9 43 34.1 1.25 0.83 – 1.87 0.2800
Total 635 - 396 - - - -
Cigarette smoking 0.0010
Never smoked 213 68.9 96 31.1 1.00 - -
Given up smoking 297 56.7 227 43.3 0.58 0.43 – 0.79 0.0005
Ever smoked 175 65.3 93 34.7 0.84 0.59 – 1.20 0.3545
Total 685 - 416 - - - -
AR%
RR 1
RR
=
−( )
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Discussion
In our setting there was no statistically significant associa-
tion between unacceptably long total delays and living in
a different district from the unit of treatment, negative
smears, older age, female sex and alcoholism. We found
independent, statistically significant association with long
delays and being unemployed, having loss of weight as
one of the symptoms, and living in two of the six health
districts.
One of the limitations of the study is that we were not able
to separate patient delay from health services delay. It is,
therefore, possible that some associations are specific to
one of these kinds of delay.
Table 2: Socio-economic factors and total delay in pulmonary tuberculosis treatment. Recife, 2001–2003.
Total delay in treatment
Socio-economic factors Unacceptable (> 60 days) Acceptable (≤ 60 days) Crude OR 95% CI P value
N % N %
Employment
Employed 282 57.3 210 42.7 1.00 - -
Unemployed 404 65.9 209 34.1 1.43 1.12 – 1.83 0.0035
Total 686 - 419 - - - -
Literacy
Yes 540 61.6 337 38.4 1.00 - -
No 146 64.0 82 36.0 1.11 0.82 – 1.50 0.4951
Total 686 - 419 - - - -
Income of Head of household (MW) 0.7356
≥ 5 22 59.5 15 40.5 1.00 - -
2 to < 5 75 66.4 38 33.6 1.34 0.62 – 1.88 0.4461
1 to < 2 184 63.7 105 36.3 1.19 0.59 – 2.40 0.6176
< 1 327 61.5 205 38.5 1.08 0.55 – 2.14 0.8086
Total 608 - 363 - - - -
Civil status 0.9600
Married 251 62.4 151 37.6 1.00 - -
Divorced, widowed or separated 64 62.7 38 37.3 1.01 0.64 – 1.58 0.9544
Single 341 61.7 212 38.3 0.96 0.74 – 1.26 0.8078
Total 656 - 401 - - - -
Number of individuals per Household 0.3897
1 – 2 160 65.3 85 34.7 1.00 - -
3 – 5 345 60.2 228 39.8 0.80 0.59 – 1.09 0.1700
≥ 6 165 61.6 103 38.4 0.85 0.59 – 1.22 0.3803
Total 670 - 416 - - - -
Table 3: Contact with tuberculosis and total delay in pulmonary tuberculosis treatment. Recife, 2001–2003.
Total delay in treatment
Contact history Unacceptable (> 60 days) Acceptable (≤ 60 days) Crude OR 95% CI P value
N % N %
Knows someone with tuberculosis
Yes 305 63.0 179 37.0 1.00 - -
No 375 61.4 236 38.6 0.93 0.72 – 1.19 0.5782
Total 680 - 415 - - - -
Recent contact with someone with tuberculosis 0.8554
< 1 year 151 63.4 87 36.6 1.00 - -
≥ 1 year 128 61.8 79 38.2 0.93 0.63 – 1.37 0.7263
Not known 375 61.4 236 38.6 0.91 0.67 – 1.24 0.5769
Total 654 - 402 - - - -
Household contact with a case of tuberculosis
Yes 104 62.7 62 37.3 1.00 - -
No 198 63.1 116 36.9 1.01 0.68 – 1.50 0.9301
Total 302 - 178 - - - -
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Some of the associations absent (for example with being
a heavy drinker) [8] may be due to methodological limi-
tations. We did not use the CAGE standard questionnaire
to ascertain alcoholism. Another limitation of the study of
the impact of the Family Health Program is that we did
not ask whether there was a visit from the FHP after the
onset of the symptoms or even whether symptoms were
addressed during a visit.
In contrast to results reported in the literature, it was
found that a history of contact with a patient with tuber-
culosis did not decrease delays. We expected this to act as
a proxy variable for knowledge about the disease [5,7,9].
However, none of the variables relating to previous con-
tact with a patient with TB was associated with treatment
delay. Again in contrast to other studies [2,7,16], being
smear-positive was not associated with a shorter delay and
most of those patients (64.1%) did not start early treat-
ment and continued to contribute to transmission. The
only symptom that was associated with shorter delays was
loss of weight. Productive cough, even when associated
with haemoptysis, did not lead to shorter delays in the
population studied, in contrast to the findings of other
authors [8,14,16]. Our findings, taken as a whole, may
suggest that it is not specific knowledge of tuberculosis per
se, but rather a general awareness of health and attitude
towards prevention and early care that leads to shorter
delays.
If one assumes that the risk of delay associated with liter-
acy, age and sex is mediated by difficulty of access, one
could say that, in this case, access to care does not appear
to be a problem. In contrast to results reported in the lit-
erature [2,4,8,13-15], we found no association with age,
sex or literacy. Associations have been reported between
travelling time, distance to health service etc. [7,8,17] in
the literature. In our study, factors directly relating to
health care, such as whether the treatment unit was in the
same neighborhood of residence, showed no association.
This lack of association, however, could also be inter-
preted to mean that access is not difficult in this urban set-
ting, but that ease of access did not decrease delays, as
those attending health units outside their neighborhood
or district of residence show the same length of delay.
Decentralization has been introduced to improve access
and we expected those patients being treated in their own
neighborhood of residence to exhibit shorter delays.
Another of the health service variables, however, did
Table 4: Clinical features and symptoms and total delay in pulmonary tuberculosis treatment. Recife, 2001–2003.
Total delay in treatment
Clinical features and symptoms Unacceptable (> 60 days) Acceptable (≤ 60 days) Crude OR 95% CI P value
N % N %
Previous TB treatment
Yes 147 60.5 96 39.5 1.00 - -
No 537 62.5 322 37.5 1.08 0.81 – 1.45 0.5666
Total 684 - 418 - - - -
Productive cough
Yes 418 62.4 252 37.6 1.00 - -
No 259 61.1 165 38.9 0.94 0.73 – 1.21 0.6655
Total 686 - 419 - - - -
Haemoptysis
Yes 94 56.6 72 43.4 1.00 - -
No 585 62.9 345 37.1 1.29 0.92 – 1.81 0.1256
Total 679 - 417 - - - -
Loss of weight
Yes 451 59.6 306 40.4 1.00 - -
No 225 68.8 102 31.2 1.49 1.13 – 1.97 0.0041
Total 676 - 408 - - - -
HIV co-infection 0.6964
Yes 219 63.8 124 36.2 1.00 - -
No 18 64.3 10 35.7 0.98 0.43 – 2.19 0.9631
Not known 449 61.3 284 38.7 0.87 0.39 – 1.92 0.7467
Total 686 - 418 - - - -
Acid fast bacilli in sputum
Yes 477 64.1 267 35.9 1.00 - -
No 102 63.4 59 36.6 0.96 0.67 – 1.37 0.8557
Total 579 - 326 - - - -
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Table 5: Access to health care and characteristics of health service (HS) and total delay in pulmonary tuberculosis treatment. Recife, 
2001–2003.
Total delay in treatment
Access to health care Unacceptable (> 60 days) Acceptable (≤ 60 days) Crude OR 95% CI P value
N % N %
Numbers of health units
only 1 176 63.1 103 36.9 1.00 - -
≥ 2 493 61.2 312 38.8 0.92 0.69 – 1.22 0.5859
Total 669 - 415 - - - -
HS in same district of residence
Yes 431 61.3 272 38.7 1.00 - -
No 255 63.6 146 36.4 1.10 0.85 – 1.42 0.4523
Total 686 - 418 - - - -
HS in neighborhood of residence
Yes 111 63.4 64 36.6 1.00 - -
No 575 61.9 354 38.1 0.93 0.67 – 1.30 0.7012
Total 686 - 418 - - - -
Residence in areas of FHP visits
Yes 258 60.4 169 39.6 1.00 - -
No 406 63.4 234 36.6 1.13 0.88 – 1.46 0.3196
Total 664 - 403 - - - -
Health District of treatment 0.0001
HD II 170 52.8 152 47.2 1.00 - -
HD I 57 62.6 34 37.4 1.49 0.92 – 2.41 0.0960
HD III 139 72.8 52 27.2 2.39 1.62 – 3.51 0.0000
HD IV 111 61.7 69 38.3 1.43 0.99 – 2.08 0.0553
HD V 172 67.7 82 32.3 1.87 1.33 – 2.64 0.0003
HD VI 37 55.2 30 44.8 1.10 0.64 – 1.87 0.7170
Total 686 - 419 - - - -
Table 6: Final model of characteristics of patients and health services and total delay in pulmonary tuberculosis treatment. Recife, 
2001–2003.
Adjusted OR 95% CI P value
Employment
Yes 1.00 - -
No 1.40 1.09 – 1.81 0.0079
Loss of weight
Yes 1.00 - -
No 1.54 1.16 – 2.04 0.0028
Health District (HD) 0.0001
HD II 1.00 - -
HD I 1.35 0.83 – 2.21 0.2189
HD III 2.34 1.57 – 3.47 0.0000
HD IV 1.39 0.95 – 2.04 0.0863
HD V 1.92 1.35 – 2.73 0.0002
HD VI 0.97 0.56 – 1.68 0.9395
* variables excluded from model: sex, age and haemoptysis because they were not statistically significant.
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prove to be significant: patients attending health units
located in districts III and V showed longer delays. This
did not disappear in the multivariable analysis, suggesting
that the delays were not a result of characteristics of
patients but of the way the health service is organized. Fur-
ther analysis (not presented here) showed that, in district
V, this was mainly caused by delays in diagnosing smear-
negative patients: only 10% had a delay of less than 60
days, compared with roughly 30% of the smear-positive
cases. This is, therefore, more likely to reflect the internal
organization of care (in this specific case, of diagnosis of
smear-negative cases) rather than a patient's ability to
appear at a health care unit.
In summary, 62% of patients started treatment after 60
days and half after 90 days. In our setting, delays do not
appear to be caused by difficulty of access, age, sex or alco-
holism. In this urban setting, delays seem to be linked to
unemployment and the general attitude towards health,
and reflect the way the health services are organized.
Conclusion
There is a need to monitor the impact of the FHP and
modify staff training to include active identification of
symptoms that may indicate tuberculosis, and to increase
population awareness of tuberculosis symptoms (build-
ing on the fact that the population already recognizes
weight loss), with emphasis on developing general health
awareness. A review of practices in the districts with short
and long delays, to improve health services organization,
should also be carried out.
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